What Researchers Did
Researchers conducted a prospective observational cohort study involving 51 patients to assess the effectiveness of hyperbaric oxygen treatment (HBOT) for xerostomia following radiotherapy.
What They Found
They found a statistically significant increase in saliva volume, with a mean increase of 0.9 mL over a 5-minute collection period (P = 0.016). Patients also experienced significant improvements in discomfort, with a mean VAS score decrease of 1.4 units (P < 0.001), and quality of life, with a mean score 10 points lower after treatment (P < 0.001).
What This Means for Canadian Patients
Canadian patients suffering from radiation-induced xerostomia may find hyperbaric oxygen therapy a beneficial treatment option to alleviate their symptoms. This could lead to improved comfort and quality of life for those affected by this challenging side effect.
Canadian Relevance
This study has no direct Canadian connection.
Study Limitations
A limitation of this observational study was the incomplete data for a significant portion of the initial patient cohort, with only 34% having complete data for all time points.